About Armune
Armune is a company based in Kalamazoo (United States) founded in 2008 was acquired by Exact Sciences in February 2018. Armune has raised $12.21 million across 10 funding rounds from investors including Exact Sciences, University of Michigan and Grand Angels. Armune operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Kalamazoo, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.21 M (USD)
in 10 rounds
-
Latest Funding Round
$500 K (USD), Series A
Jan 23, 2017
-
Investors
Exact Sciences
& 5 more
-
Employee Count
Not available
-
Acquired by
Exact Sciences
(Feb 05, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Armune
Armune has successfully raised a total of $12.21M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $500 thousand completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Armune
Armune has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Exact Sciences, University of Michigan and Grand Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Grand Angels is engaged in angel investing for startups.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Armune
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Armune
Investment portfolio details for Armune
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Armune
Detailed financials for Armune
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Armune Comparisons
Peer comparison for Armune
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Armune
Armune operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of Armune
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Armune
Complete news archive for Armune
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Armune
Armune was founded in 2008.
Armune is headquartered in Kalamazoo, United States. It is registered at Kalamazoo, Michigan, United States.
Armune is a funded company, having raised a total of $12.21M across 10 funding rounds to date.
The company was founded in 2008 and is located in Kalamazoo, United States, within the biotechnology sector. Diagnostic and prognostic tests for prostate, lung, and breast cancers are researched and developed to support personalized treatment decisions. These tests rely on immune system signals for early detection and improved outcomes. A validated blood test, APIFINY, is provided for prostate cancer screening as a non-PSA alternative, enabling biopsy selection for patients.
Armune's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
Armune has 6 investors. Key investors include Exact Sciences, University of Michigan, Grand Angels, Michigancrn, and Accelerate Michigan.